330 related articles for article (PubMed ID: 24996822)
1. Siglec-G/10 in self-nonself discrimination of innate and adaptive immunity.
Chen GY; Brown NK; Zheng P; Liu Y
Glycobiology; 2014 Sep; 24(9):800-6. PubMed ID: 24996822
[TBL] [Abstract][Full Text] [Related]
2. CD24-Siglec G/10 discriminates danger- from pathogen-associated molecular patterns.
Liu Y; Chen GY; Zheng P
Trends Immunol; 2009 Dec; 30(12):557-61. PubMed ID: 19786366
[TBL] [Abstract][Full Text] [Related]
3. Siglec-G-CD24 axis controls the severity of graft-versus-host disease in mice.
Toubai T; Hou G; Mathewson N; Liu C; Wang Y; Oravecz-Wilson K; Cummings E; Rossi C; Evers R; Sun Y; Wu J; Choi SW; Fang D; Zheng P; Liu Y; Reddy P
Blood; 2014 May; 123(22):3512-23. PubMed ID: 24695850
[TBL] [Abstract][Full Text] [Related]
4. CD24 and Siglec-10 selectively repress tissue damage-induced immune responses.
Chen GY; Tang J; Zheng P; Liu Y
Science; 2009 Mar; 323(5922):1722-5. PubMed ID: 19264983
[TBL] [Abstract][Full Text] [Related]
5. The Role of Siglec-G on Immune Cells in Sepsis.
Royster W; Wang P; Aziz M
Front Immunol; 2021; 12():621627. PubMed ID: 33708213
[TBL] [Abstract][Full Text] [Related]
6.
Yang J; Ma W; Wu Y; Zhou H; Song S; Cao Y; Wang C; Liu X; Ren J; Duan J; Pei Z; Jin C
Microbiol Spectr; 2021 Dec; 9(3):e0039921. PubMed ID: 34878295
[TBL] [Abstract][Full Text] [Related]
7. CD24-Siglec axis is an innate immune checkpoint against metaflammation and metabolic disorder.
Wang X; Liu M; Zhang J; Brown NK; Zhang P; Zhang Y; Liu H; Du X; Wu W; Devenport M; Tao W; Mao-Draayer Y; Chen GY; Chen YE; Zheng P; Liu Y
Cell Metab; 2022 Aug; 34(8):1088-1103.e6. PubMed ID: 35921817
[TBL] [Abstract][Full Text] [Related]
8. Copresentation of antigen and ligands of Siglec-G induces B cell tolerance independent of CD22.
Pfrengle F; Macauley MS; Kawasaki N; Paulson JC
J Immunol; 2013 Aug; 191(4):1724-31. PubMed ID: 23836061
[TBL] [Abstract][Full Text] [Related]
9. The CD24-Siglec G axis protects mice against cuprizone-induced oligodendrocyte loss: targeting danger signal for neuroprotection.
Li N; Zheng P; Liu Y
Cell Mol Immunol; 2018 Jan; 15(1):79-81. PubMed ID: 28757612
[No Abstract] [Full Text] [Related]
10. Preparation of Recombinant Siglecs and Identification of Their Ligands.
Chang LY; Low PY; Sridharan D; Gerlovin K; Angata T
Methods Mol Biol; 2020; 2132():85-98. PubMed ID: 32306317
[TBL] [Abstract][Full Text] [Related]
11. Leishmania donovani Utilize Sialic Acids for Binding and Phagocytosis in the Macrophages through Selective Utilization of Siglecs and Impair the Innate Immune Arm.
Roy S; Mandal C
PLoS Negl Trop Dis; 2016 Aug; 10(8):e0004904. PubMed ID: 27494323
[TBL] [Abstract][Full Text] [Related]
12. Extracellular CIRP decreases Siglec-G expression on B-1a cells skewing them towards a pro-inflammatory phenotype in sepsis.
Royster W; Jin H; Wang P; Aziz M
Mol Med; 2021 May; 27(1):55. PubMed ID: 34058975
[TBL] [Abstract][Full Text] [Related]
13. Induction of Siglec-G by RNA viruses inhibits the innate immune response by promoting RIG-I degradation.
Chen W; Han C; Xie B; Hu X; Yu Q; Shi L; Wang Q; Li D; Wang J; Zheng P; Liu Y; Cao X
Cell; 2013 Jan; 152(3):467-78. PubMed ID: 23374343
[TBL] [Abstract][Full Text] [Related]
14. Identification of Siglec Ligands Using a Proximity Labeling Method.
Chang L; Chen YJ; Fan CY; Tang CJ; Chen YH; Low PY; Ventura A; Lin CC; Chen YJ; Angata T
J Proteome Res; 2017 Oct; 16(10):3929-3941. PubMed ID: 28899088
[TBL] [Abstract][Full Text] [Related]
15. Targeting CD24/Siglec-10 signal pathway for cancer immunotherapy: recent advances and future directions.
Li X; Tian W; Jiang Z; Song Y; Leng X; Yu J
Cancer Immunol Immunother; 2024 Jan; 73(2):31. PubMed ID: 38279998
[TBL] [Abstract][Full Text] [Related]
16. GATA3 Encapsulated by Tumor-Associated Macrophage-Derived Extracellular Vesicles Promotes Immune Escape and Chemotherapy Resistance of Ovarian Cancer Cells by Upregulating the CD24/Siglec-10 Axis.
Chen C; Zhang L; Ruan Z
Mol Pharm; 2023 Feb; 20(2):971-986. PubMed ID: 36547230
[TBL] [Abstract][Full Text] [Related]
17. Decoration of T-independent antigen with ligands for CD22 and Siglec-G can suppress immunity and induce B cell tolerance in vivo.
Duong BH; Tian H; Ota T; Completo G; Han S; Vela JL; Ota M; Kubitz M; Bovin N; Paulson JC; Nemazee D
J Exp Med; 2010 Jan; 207(1):173-87. PubMed ID: 20038598
[TBL] [Abstract][Full Text] [Related]
18. Sialic acids siglec interaction: a unique strategy to circumvent innate immune response by pathogens.
Khatua B; Roy S; Mandal C
Indian J Med Res; 2013 Nov; 138(5):648-62. PubMed ID: 24434319
[TBL] [Abstract][Full Text] [Related]
19. A versatile soluble siglec scaffold for sensitive and quantitative detection of glycan ligands.
Rodrigues E; Jung J; Park H; Loo C; Soukhtehzari S; Kitova EN; Mozaneh F; Daskhan G; Schmidt EN; Aghanya V; Sarkar S; Streith L; St Laurent CD; Nguyen L; Julien JP; West LJ; Williams KC; Klassen JS; Macauley MS
Nat Commun; 2020 Oct; 11(1):5091. PubMed ID: 33037195
[TBL] [Abstract][Full Text] [Related]
20. The sialoglycan-Siglec glyco-immune checkpoint - a target for improving innate and adaptive anti-cancer immunity.
Bärenwaldt A; Läubli H
Expert Opin Ther Targets; 2019 Oct; 23(10):839-853. PubMed ID: 31524529
[No Abstract] [Full Text] [Related]
[Next] [New Search]
